Skip to content

Zprávy skupiny

  • Aspen donates electronic devices valued at R2.4 million to assist UP medical students
    on 06.05.2020

    An Aspen Pharmacare initiative Johannesburg - JSE Limited listed Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company headquartered in South Africa, has donated 600 internet-enabled electronic devices valued at R2.4 million to support students from the Faculty of Health Sciences at the University of Pretoria (UP). Stavros Nicolaou, Aspen Pharmacare Senior Executive: Strategic Trade said, “Aspen is humbled to serve South Africa in its time of need, as we work together to fight the COVID-19 pandemic.  The provision of these devices to students not only helps to ensure that they have continued access to online education, but also limits their need for travel.  This donation will help curb the transmission-risk of the virus as the new academic semester begins, allowing students to undertake their studies remotely. We are deeply committed to supporting the sectors and communities in which we operate, both during the current crisis, and in the longer term, as we assist to create sustainable communities in South Africa.” Professor Robin Green, UP Chairperson of the School of Medicine said, “While the COVID-19 crisis has created a world of hurt and sadness, it has also allowed the kindness and generosity of the world to shine. We appreciate the generous donation that Aspen has made to the Faculty to assist students with distance learning and to enable them to continue with the 2020 academic year.” Following a rigorous screening process by the UP, the devices were earmarked for selected registered Faculty of Health Sciences students who attend classes regularly and who are unable to purchase the device for themselves. The tablets were handed over under strictly controlled hygiene and safety protocols, ahead of the commencement of remote lectures and training that resumed on 4 May 2020. Nicolaou added that this donation is in line with the country’s ambitions of harnessing digital innovation to benefit disadvantaged students, during these difficult times and into the future. “The donation of equipment further complements the University of Pretoria’s efforts to ensure that students from medicine and the other health science disciplines are able to continue with their curriculum and to minimise disruptions to the academic year,” said Nicolaou. The post Aspen donates electronic devices valued at R2.4 million to assist UP medical students appeared first on Aspen Pharmacare.

  • AGI: Covid-19 support in Mauritius
    on 05.05.2020

    Aspen donates anaesthetic medicines to patients in critical condition An Aspen Global Incorporated Initiative Ministry of Health, Emmanuel Anquetil Building, Port Louis, 29 April 2020: In a major contribution in our fight against Covid-19, Aspen Global Incorporated, the Mauritian subsidiary of Aspen Pharmacare Holdings (a multinational pharmaceutical company), has donated approximately 30,000 vials of three anaesthetic products (Diprivan, Nimbex and Tracrium) used to treat patients in intensive care units (ICUs) with Acute Respiratory Distress Syndrome (ARDS). Due to the current COVID-19 crisis, these medically critical products have become scarcer as demand has increased worldwide. It is in this context that Aspen has offered its help to Mauritius by donating a shipment of these products to the government, which were formally remitted to the Minister of Health and Wellness, Kailesh Jagutpal, during an official ceremony held on Wednesday the 29th of April 2020, at the Minister’s office in Port Louis. “We are really pleased to have offered our assistance to Mauritius in these testing times. Our sole intention is to give a helping hand to the country where we have based our global business. We all need to pool our resources to rid the world of this invisible enemy as quickly as possible with the fewest casualties. This initiative is in line with the Aspen Group’s motto: ‘Health Care, We Care’; and our aspirations are to care for our patients, our employees and our community. Though our stock for this product is limited in view of global demand, we will continue to consider all requests from Mauritius as a top priority,” says Samer Kassem, CEO of Aspen Global Incorporated. “I take note, with immense pleasure, of this act of generosity on behalf of Aspen. This is yet another example of the healthy and precious collaboration between the public and the private sector, I am confident that the existing robust relationship between the two sectors will keep on strengthening. Aspen’s initiative in providing us with this important stock of anaesthetic drugs, in spite of the challenging and difficult global situation when it comes to movement of goods, is very much appreciated. The ongoing COVID-19 situation is a planetary challenge, I remain confident that together, with all our stakeholders involved in the fight against the novel coronavirus, we will succeed in ascertaining that our population is provided with the best and most efficient health care possible”, states Kailesh Jagutpal, Minister of Health and Wellness. These high-end pharmaceutical products are indeed essential in the process of intubating patients for ventilation, as they induce light to deep sedation and muscle relaxation. Securing this stock is very important at this stage of the epidemic as it extends the country’s capacity to care for the most serious forms of illnesses due to Covid-19 in our hospitals. Indeed, this coronavirus leads, in some cases, to ARDS. The anaesthetics donated by Aspen, the use of which has been confirmed by the Covid-19 Guidelines issued by the European Society of Intensive Care, helps doctors to find the right synchronisation between the patient and the mechanical ventilator. The advisor to the Government of Mauritius, Dr Catherine Gaud, who has been instrumental in linking Aspen to the authorities was also present at the ceremony and lauded this initiative “Such partnerships with the private sector show the sense of solidarity that all Mauritians are demonstrating in the wake of this disease. How a country combats the COVID-19 and any other pandemic of this amplitude will also depend on such solidarity.” This initiative is very important to Aspen as it is in line with its commitment to supporting the communities in which it operates. Mauritius has been the launchpad for the global expansion of the group since 2008 and, the passionate staff and their families have been very active in carrying out social initiatives towards the community since its establishment 12 years ago. While Covid-19 is yet another challenge, bringing hardship to people around the world, it also represents a once-in-a-lifetime opportunity to “reset” our humanity and connect with others and nature as never before. The post AGI: Covid-19 support in Mauritius appeared first on Aspen Pharmacare.

  • Message to all Aspen employees from Gus Attridge
    on 06.04.2020 The post Message to all Aspen employees from Gus Attridge appeared first on Aspen Pharmacare.

  • Aspen responds to President Cyril Ramaphosa’s call to action on COVID-19
    on 17.03.2020

    Johannesburg - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced that the Group is actively focused on employees carrying out best practices in respect of the prevention and containment of COVID-19 while ensuring continued supply of medicines to patients. Stephen Saad, Aspen Group Chief Executive said, “As articulated by our President Cyril Ramaphosa, COVID-19 raises unprecedented challenges for both South Africa and the world. These challenges require an extraordinary response from every sector of society, not least the domestic pharmaceutical industry. These challenges have been exacerbated by the ban from India on the export of a range of pharmaceutical products and their raw materials.” “Aspen is in discussion with the South African Government to make available, wherever feasible, its extensive South African oral solid and liquid pharmaceutical manufacturing operations for priority treatment of the South African public. This will entail adjusting some of Aspen’s production plans.” “We echo our President’s appeal to the South African public for their assistance during this unprecedented time. Aspen has seen a spike in inquiries and demand in some of its over–the-counter pain, respiratory and colds and flu medicines. We wish to emphasise that our supply chain is currently robust and panic-buying will create unnecessary stress.” “At this time, Aspen wishes to reassure the South African public of its commitment to them.” The post Aspen responds to President Cyril Ramaphosa’s call to action on COVID-19 appeared first on Aspen Pharmacare.

  • Aspen increases revenue and progresses on medium-term priorities
    on 05.03.2020

    Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 31 December 2019. GROUP PERFORMANCE (CONTINUING OPERATIONS) Aspen increased revenue by 3% to R18,4 billion for the six months ended 31 December 2019. Commercial Pharma increased 2% to… The post Aspen increases revenue and progresses on medium-term priorities appeared first on Aspen Pharmacare.

Scroll To Top